EPISODE · Jan 20, 2026 · 1H 23M
GLP-1 NEWS: Access at Risk – What Current Lawsuits and Legislation Mean
from The Plus SideZ: A GLP-1 Guide to Metabolic Health · host Kim Carlos
Linktree for Community Resourceshttps://linktr.ee/theplussidezpodcast_________________________________________________________________________In this episode, we break down the latest GLP-1 news around policy and legal developments impacting access to compounded GLP-1 medications in the United States.We’re joined by special news correspondents Sabina Henn, an obesity advocate from GLPWinner.com, and Maria Rising, a GLP-1 reporter on TikTok and obesity advocate. Both are deeply involved in obesity care advocacy and work on and off the internet to protect patient access to treatment.We begin with the broader national strategy shaping current GLP-1 policy, then walk through key federal and state actions, including the SAFE Drug Act (SR 6509), Indiana SB 282, and Florida SB 860 / HB 877. We explain how these bills could restrict access to compounded GLP-1 medications and why that poses a serious problem for patients who cannot take brand-name drugs or cannot afford them due to lack of insurance coverage and high costs.We also cover the ongoing lawsuits between GLP-1 drug manufacturers and compounding pharmacies, including the Strive lawsuit, and examine the use of racketeering claims as a legal strategy. Throughout the episode, we focus on the real-world impact of these actions and how they could affect millions of patients relying on compounded GLP-1 medications for obesity and metabolic disease care.We close with clear ways listeners can stay informed, engage, and help protect access to care.Lawsuit Tracker https://docs.google.com/spreadsheets/d/1XoaPEVWv5AxUJyoluaD-eExTPHK3GClIiV0xyI9rXqc/edit?usp=sharingFollow Sabina: Tiktok: https://www.tiktok.com/@lawliepop?lang=enInstagram: https://www.instagram.com/glpwinner/X: https://x.com/lawliepop?lang=enYouTube: https://www.youtube.com/ @lawliepop Follow Maria TikTokhttps://www.tiktok.com/@tirzepatidetales?_r=1&_t=ZP-93ELkA5nG9eSubstack https://substack.com/search/tirzepatidetales?searching=profile_________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #GLP1NewsSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Honest Care can Appeal GLP-1 Denials. Go to FindHonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
What this episode covers
Linktree for Community Resources https://linktr.ee/theplussidezpodcast _________________________________________________________________________ In this episode, we break down the latest GLP-1 news around policy and legal developments impacting access to compounded GLP-1 medications in the United States. We’re joined by special news correspondents Sabina Henn, an obesity advocate from GLPWinner.com, and Maria Rising, a GLP-1 reporter on TikTok and obesity advocate. Both are deeply involved...
NOW PLAYING
GLP-1 NEWS: Access at Risk – What Current Lawsuits and Legislation Mean
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m